ArticleClinical and experimental medicine2023

miR-146a-3p as a potential novel therapeutic by targeting MBD2 to mediate Th17 differentiation in Th17 predominant neutrophilic severe asthma.

Wentao Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.